Skip to main content

HROW

Stock

HROW

Stock
Health Care
Drug Manufacturers - Specialty & Generic

Performance overview

HROW Price
Price Chart

Forward-looking statistics

Beta
0.79
Risk
77.12%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans.

Company info

SectorHealth Care
IndustryDrug Manufacturers - Specialty & Generic
Employees119
Market cap$642.9M

Fundamentals

Enterprise value$1.3B
Revenue$212.9M
Revenue per employee
Profit margin-10.19%
Debt to equity410.02

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$0.61
Dividend per share
Revenue per share$5.96
Avg trading volume (30 day)$14M
Avg trading volume (10 day)$13M
Put-call ratio

Macro factor sensitivity

Growth+7.3
Credit-0.2
Liquidity-3.7
Inflation+7.1
Commodities+2.2
Interest Rates-1.8

Valuation

Dividend yield0.00%
PEG Ratio30.83
Price to sales5.47
P/E Ratio30.83
Enterprise Value to Revenue6.01
Price to book20.06

Upcoming events

Next earnings dayMay 9, 2025
Next dividend day
Ex. dividend day

News

Harrow (HROW) Reports Q1 Loss, Lags Revenue Estimates

Harrow (HROW) came out with a quarterly loss of $0.38 per share versus the Zacks Consensus Estimate of $0.02. This compares to loss of $0.28 per share a year ago.

Zacks Investment Research (May 8, 2025)
Top 3 Health Care Stocks That May Crash This Quarter

As of July 3, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Benzinga (July 3, 2024)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free